Ledger.Open graph →
SEC Form D · filed December 18, 2013

OrPro Therapeutics, Inc

Offering
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Stephen J. Blewitt · BOSTON, MAExec · DirectorTammy A. Pendergast · Southport, CTDirectorDaniel C. Budde · BOSTON, MADirectorBrian A. Albert · BOSTON, MADirectorEtienne D. Dumais · Montreal, Quebec, CanadaExec · DirectorPaul A. Fishbin · BOSTON, MADirectorScott A. Mcfetridge · BOSTON, MAExec · DirectorScott B. Garfield · BOSTON, MADirectorTheophilus Ulmer · Austin, TXDirectorMartin J. Duvall · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗